Posted by Michael Wonder on 29 Apr 2020
FDA in ‘ongoing’ talks with Gilead to make remdesivir available to coronavirus patients ‘as quickly as possible’
29 April 2020 - The FDA has been in “sustained and ongoing” discussions with Gilead Sciences to make antiviral drug remdesivir available to COVID-19 patients “as quickly as possible, as appropriate,” the agency said Wednesday.
Earlier in the day, White House health advisor Dr. Anthony Fauci said data from a coronavirus drug trial testing Gilead’s drug showed “quite good news” and sets a new standard of care for COVID-19 patients.
Speaking to reporters from the White House, Fauci said he was told data from the trial showed a “clear-cut positive effect in diminishing time to recover.”
